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Abstract:  
 
Data from the Substance Abuse and Mental Health Services Administration’s Integrated 
Database (IDB) were used to examine the service use patterns of individuals with possible opiate 
use disorders in Washington State. Results indicate that regardless of Medicaid enrollment status, 
individuals who received mental health (MH) or substance abuse (SA) services only through 
state agencies received no inpatient substance abuse service. Furthermore, when compared with 
individuals who received at least one MH/SA service through Medicaid, those who received 
services only through the state agencies were less likely to have received any MH services and 
were more likely to have received residential SA services. This analysis highlights the 
importance of using integrated client data in providing a more comprehensive understanding of 
services to inform policy and raises significant questions about how regulatory requirements 
affecting different funding mechanisms might drive settings of care in ways not related to the 
care needed. 
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Article:  
 
Introduction 
 
The use of, abuse of, and dependence on opiates is a major public health concern.1,2 Although 
only about 0.1% of the U.S. population reported past-year heroin use in 1998,3 heroin and other 
opiate use accounted for about 30% of total spending for illicit drug use treatment and almost 
18% of spending on drug-related crime.4 Psychological and physical health problems were also 
common among heroin and other opiate users in the mid- to late-1990s.5 As recently as 2003, 
heroin accounted for 23% of the mentions of substances used among emergency room patients 
and 41% of drug-related deaths recorded by medical examiners or coroners.6 The social costs of 
opiate abuse are not limited to illegal drugs. A recent study suggests that in 2001, the social cost 
of prescription opioid abuse in the United States was $8.6 billion.7 
 
Despite the overwhelming societal costs associated with opiate use disorders, few studies have 
investigated the substance abuse (SA) or mental health (MH) treatment service patterns of 
individuals suffering from opiate abuse or dependence; rather, most studies focus almost 
exclusively on those in methadone maintenance treatment.8–10 These studies suggest that the 
co-occurrence of MH problems and other illicit drug dependence is quite high among individuals 
with an opiate use disorder.11–13 Yet, despite the increased incidence of MH conditions, 
individuals with a substance use disorder may not receive adequate levels of MH care beyond 
that directly related to their substance use disorder.10,11,14,15 Given these findings and the 
major public health concerns caused by opiate abuse and dependence, the lack of information 
about the broader MH/SA treatment service patterns of individuals with an opiate use disorder is 
a critical gap in the knowledge base informing policies affecting this population. 
 
This study used data from the Substance Abuse and Mental Health Services Administration’s 
(SAMHSA) Integrated Database (IDB) on individuals in Washington State with an indication of 
an opiate use disorder to determine what MH/SA services they received and through which 
auspice (i.e., Medicaid or state agency) they received them. Findings from this study offer two 
contributions to the current literature. First, the IDB presents a unique opportunity to study the 
behavioral health care utilization of individuals with opiate use disorders because it contains 
service use data linked at the client level from Washington Medicaid and from the Washington 
State Department of Social and Health Services’ (DSHS) Mental Health Division (MHD) and 
Division of Alcohol and Substance Abuse (DASA). The combination of Medicaid and DSHS 
data represented in the IDB provides a more comprehensive picture of service use patterns than 
might be obtained from studies that focus on only one data source. Second, the late 1990s is 
often characterized as a time of a heroin epidemic in the United States.16 Therefore, examining 
the MH/SA treatment service use patterns of individuals with opiate use disorders during this 
period can provide an especially relevant baseline for today’s policy makers as they attempt to 
address issues surrounding the emergence of new opiates. 
 
Data and Methods 
 
This paper uses IDB data on Washington State from three full calendar years (1996–1998). For a 
more detailed description of the IDB, see Coffey et al.,17 and for a detailed description of the 
methods used to link IDB service records across state organizations, see Whalen et al.18 In 
addition to service use information, the IDB contains information on patient demographics (e.g., 
age, gender, race/ethnicity), Medicaid enrollment status, MH/SA diagnosis and service codes, 
and limited provider information. 
 
Study population 
 
The study population for this analysis consists of individuals who have at least one record in the 
IDB indicating an opiate use disorder. An opiate use disorder could be indicated by one or more 
of the following: a diagnosis (either primary or secondary) of an opiate use disorder, a provider 
type indicative of opiate treatment, a service or procedure code indicative of opiate treatment 
(including methadone maintenance therapy but excluding methadone used for pain 
management), or a report of an opioid as the drug of choice. Opiate use disorder diagnoses were 
defined using the International Classification of Diseases, 9th Revision, Clinical Modification 
(ICD-9-CM). ICD-9-CM codes of 304.0 or 305.5, including any subclassifications, were used to 
identify opiate dependence and abuse, respectively. State-specific provider codes were used to 
identify opiate treatment providers. Both standard [e.g., Healthcare Common Procedure Coding 
System (HCPCS)] and local procedure codes were used to identify opiate treatment services. 
Finally, drug-of-choice information was available from self-reports obtained by state agencies 
during client intake. In some cases, the drug-of-choice information was obtained more than 1 
year before or after any SA or MH service provision, but these cases represent less than 3% of 
the sample. 
 
Preliminary analyses revealed that very few agency service records include diagnosis codes, but 
most Medicaid records do. Further investigation revealed that this is not an issue of Medicaid 
requiring a diagnosis for eligibility, but rather an issue of the data systems themselves. Agency 
services do not require a diagnosis code for reimbursement, so agency data systems do not track 
diagnosis. Conversely, Medicaid services often require a diagnosis for reimbursement, so 
Medicaid data systems track diagnosis. Because the presence or absence of a diagnosis is almost 
completely confounded by the use or nonuse of Medicaid services, information on service use 
differences associated with an opiate use disorder diagnosis is not presented. 
 
Client classification 
 
One of the primary objectives of this study was to examine the extent to which the MH/SA 
service use patterns of individuals with an opiate use disorder varied based on whether their 
MH/SA services were tracked by Medicaid or a state MH/SA agency. Importantly, service 
tracking may, or may not, be associated with full or partial financial coverage. Accordingly, for 
this study, individuals were classified based on the data source (Medicaid or state MH/SA 
agency) from which their IDB MH/SA service records were obtained. Based on this information, 
individuals were classified into three categories: 
 
 Any Medicaid service: individuals who have at least one Medicaid MH/SA service 
record, regardless of whether they have MH/SA state agency service records 
 Agency services only with Medicaid enrollment: individuals who have at least one 
MH/SA state agency service record and were Medicaid-enrolled at some point between 
their first and last observed MH/SA service record but have no record of receiving an 
MH/SA service through Medicaid 
 Agency services only without Medicaid enrollment: individuals who have at least one 
MH/SA state agency service record and were not Medicaid-enrolled at any time between 
their first and last observed MH/SA service record 
 
Because the IDB integrates information from state Medicaid and state MH/SA agency data 
sources, overlapping records may occur if Medicaid reimburses a bill, but the state agency 
provides the service. To avoid overstating utilization rates, only one service date was counted for 
cases in which the same client, service type (MH or SA), modality/setting of service [i.e., 
inpatient (IP), residential/long-term care, or outpatient (OP)], and service date were reported on 
both the Medicaid and state agency databases. Individuals with these types of records were 
classified as any Medicaid service. Importantly, although individuals in the any Medicaid service 
group may have received any number, or even the majority, of their services through the state 
agency, preliminary analyses indicated that individuals who received both Medicaid and agency 
services were more similar to those who received only Medicaid services than they were to those 
who received only agency services. For this reason, individuals receiving any Medicaid service 
were combined into a single category. 
 
In addition to the client categorization described above, the standard IDB client classification 
was also used. The IDB client classification was used to identify individuals who received 
services for only MH conditions (MH-only), only SA conditions (SA-only), or co-occurring 
conditions (both MH and SA) during the study period. The IDB classifies individuals as having 
co-occurring conditions if they had any of the following within the 3-year study period: (1) both 
a primary MH and a SA diagnosis, (2) a primary MH and a secondary SA diagnosis, or (3) a 
primary SA and a secondary MH diagnosis. Individuals classified as having co-occurring 
conditions did not necessarily have MH and SA conditions concurrently. A client with an MH 
record at the beginning of the study period and an SA record at the end of the study period, for 
example, is classified by the IDB as having co-occurring conditions. In the absence of diagnosis 
information, MH-only and SA-only classifications were assigned based on the type of service 
received during the study period (see Coffey et al.17 and Bray et al.19 for a detailed definition of 
the primary MH/SA diagnosis category). 
 
The IDB client classification does not incorporate information on secondary diagnoses unless a 
primary MH/SA diagnosis is also present, nor does it incorporate drug-of-choice information 
from state agency intake records. Because both of these pieces of information were used to 
identify individuals with an opiate use disorder for this study, it is possible for individuals with 
an opiate use disorder to be classified as MH-only or having received no MH/SA service based 
on the IDB client classification. 
 
Service classification 
 
Standard IDB service type classifications were used to classify the MH/SA services received by 
individuals with an opiate use disorder. The IDB MH/SA service type classifies MH/SA service 
records as either MH or SA and within MH/SA as IP, residential, or OP. Many inpatient 
programs are part of psychiatric or general hospitals and generally use a medical model of 
substance disorders in which intensive medication and counseling are provided over a relatively 
short period of time.20 Residential programs typically are provided in a free-standing, designated 
residential treatment facility. Residential treatment is usually of longer duration than IP treatment 
and relies less on medical professionals. Residential treatment provides organized services by 
designated treatment personnel who provide a planned regimen of care in a 24-h setting and is 
intended to serve clients who need a safe and stable living environment to develop sufficient 
recovery skills.21 For a complete description of the criteria used to classify services, see Coffey 
et al.17 The vast majority of individuals with a possible opiate use disorder have at least 1 SA 
service record, but relatively few have MH service records; therefore, the IP, residential, and OP 
subclassifications were examined for SA service records but not for MH service records. 
 
Service encounters 
 
An individual’s total number of service encounter dates was defined as the count of unique dates 
within the MH/SA service window on which the individual had a record with at least one service 
of a given service category (MH, IP SA, residential SA, or OP SA). Within a single IP or 
residential stay, each daily service encounter date was counted separately. Using standard IDB 
definitions for the full SA population, this same information is presented for the broader SA 
population, excluding individuals with an indication of an opiate use disorder. 
 
Methods 
 
To characterize the level of contact individuals with an opiate use disorder have with the public 
treatment system, the analysis examined four key domains: (1) the proportion of clients using 
services, (2) the median length of the service window (i.e., the length of time between an 
individual’s first and last MH/SA service), (3) the number of days of Medicaid enrollment within 
the service window, and (4) the number of unique MH/SA encounter dates within the service 
window. 
 
Regression analyses were conducted to assess whether the service use patterns of individuals 
with an opiate use disorder differed significantly across the client classification categories after 
controlling for differences in the length of the MH/SA service window, the length of Medicaid 
enrollment, and demographics across the client categories. First, logistic regression models of the 
following form were estimated: 
 
Prob(SERVi=1)=f(β1DEMOGi+β2GROUPi+β3WINDOWi+β4ENROLLi), 
 
where SERV i is a series of indicators for receipt of services of a given type. For the regression 
analyses, any MH services and OP and residential SA services were considered. Regression 
analyses for IP SA services were not conducted because those services were received solely by 
the any Medicaid service group. DEMOG i is a set of demographic characteristics (i.e., gender, 
age, and race/ethnicity); GROUP i is a vector of variables representing the data source categories 
of any Medicaid service (the referent), agency services only with Medicaid enrollment, and 
agency services only without Medicaid enrollment; WINDOW i is the MH/SA service window 
length in days; and ENROLL i is the months of Medicaid enrollment (including 0 months). The 
βs are vectors of coefficients to be estimated. Variables reflecting the primary diagnosis 
categories are not included because much of the information used to classify individuals as MH-
only, SA-only, or co-occurring was also used to classify services as MH or SA. 
 
Next, regressions of the following form were run on days of service, conditional on service use: 
 
In(DAYSi)=β1DEMOGi+β2GROUPi+β3WINDOWi+β4ENROLLi+εi, 
 
where DAYS i is a set of variables reflecting the unique days of care for each of the same types 
of care, and all other terms are as previously defined. Consistent with the recommendations of 
Manning and Mullahy,22 generalized linear model (GLM) estimation with a log link and a 
gamma distribution on the natural scale was used rather than ordinary least squares (OLS) on the 
log scale. 
 
Results 
 
Table 1 presents the demographic characteristics of the individuals identified as having an opiate 
use disorder in the IDB. For a point of comparison, Table 1 also presents the same information 
for the general IDB SA population, as defined in Coffey et al.,17 but excluding individuals with 
an opiate use disorder. Individuals with an opiate use disorder accounted for approximately 16% 
of the population with any SA disorder. In terms of demographics, when compared with 
individuals with a non-opiate SA disorder, individuals with an opiate use disorder are less likely 
to be male and more likely to be adults (as opposed to youth or elderly), but only minor 
differences in the distribution of clients across racial/ethnic categories are observed. Individuals 
with an opiate use disorder are less likely to be in the SA-only IDB client classification category. 
This is largely by construction because as discussed earlier, the current paper uses more inclusive 
data to identify individuals with a possible opiate use disorder than is used by the IDB client 
classification. Individuals with an opiate use disorder were more likely to have IP and residential 
SA services than the general SA population, but less likely to have any OP SA service. 
Individuals with an opiate use disorder were also more likely to have received any MH service 
compared to the general SA population. They also had longer MH/SA service windows, 
indicating longer periods of contact with the public MH/SA treatment system, and were more 
likely to be in the any Medicaid service and the agency services only with Medicaid enrollment 
groups. 
 
 
 
Figure 1 presents the median MH/SA service window and length of Medicaid enrollment across 
individuals with a possible opiate use disorder in each of the data source categories. The any 
Medicaid service group has the longest median MH/SA service window and the most median 
days of Medicaid enrollment within that window, followed by the agency services only with 
Medicaid enrollment group and then the agency services only without Medicaid enrollment 
group. Because the analysis only examines Medicaid enrollment within the MH/SA service 
window, the length of Medicaid enrollment is always less than the total service window length. 
The total Medicaid enrollment of an individual may be greater than that reported here, but by 
definition of the service window, no MH/SA service use occurred during days of Medicaid 
enrollment not captured by this measure. Importantly, the any Medicaid service group may have 
received substantial services from MH or SA state agencies, because individuals in this group are 
categorized as any Medicaid service only because they received at least one Medicaid service. 
 
 
 
Figures 2 and 3 present the probability of service use and the median days of service conditional 
on service utilization for each of the data source categories. IP SA care was not included in 
Figures 2 and 3 because only individuals in the any Medicaid service group had IP SA utilization 
(the conditional median days of IP SA care for that group were 6). Figure 2 suggests that the two 
agency services only groups are more likely to receive residential SA services and are less likely 
to receive OP SA services or MH services. Conditional on receipt of services, Figure 3 suggests 
that the agency services only with Medicaid enrollment group received the most days of 
residential SA service, the agency services only without Medicaid enrollment group received the 
most days of OP SA care, and the any Medicaid services group received the most days of MH 
care. 
 
 
 
 
 
Table 2 presents results from the logistic regressions, including logit coefficients, their standard 
errors, and associated odds ratios (ORs) for the data source grouping variables. For all other 
covariates, only the estimated logit coefficients and their standard errors are presented. Table 2 
shows that even after controlling for the longer service window and more months of Medicaid 
enrollment, the pattern observed in Figure 2 still holds. Compared with individuals in the any 
Medicaid service group, individuals in the agency services only with Medicaid enrollment and 
the agency services only without Medicaid enrollment groups had significantly higher odds of 
receiving at least residential SA service (OR = 2.941 and OR = 1.376, respectively) and lower 
odds of receiving any OP SA (OR = 0.311 and OR = 0.162, respectively) or any MH service 
(OR = 0.217 and OR = 0.110, respectively). Briefly examining the results for the control 
variables in the regression, females are significantly less likely to receive residential SA services. 
The racial/ethnic categories that are statistically significant suggest that racial/ethnic minorities 
are less likely than non-Hispanic whites to receive services of any type. Age categories reflecting 
individuals both younger and older than the referent of 36 to 40 were also, in general, less likely 
to receive services of any type when the associated coefficients were statistically significant. The 
exception is that individuals aged 21 to 35 with an opiate use disorder were more likely to 
receive residential SA services. Results with regard to demographic characteristics, especially 
race/ethnicity, should not be interpreted as evidence of disparities, however. Rather, they indicate 
the differential representation of demographic groups across the data and highlight the 
importance of controlling for those factors when assessing statistical significance. Unexpectedly, 
months of Medicaid enrollment are positively associated with a greater likelihood of service use 
only for MH services. For both types of SA care examined, longer Medicaid enrollment was 
negatively associated with the probability of service use, although the relationship was not 
significant for residential care. 
 
 
 
 
 
Table 3 presents the regression results for days of care, conditional on having at least 1 day of 
service of that type of care. Because the natural logarithm of days of care is the dependent 
variable, the coefficient estimates, standard errors, and associated percentage changes for the 
data source categories are presented. For all other variables, only the estimated coefficients and 
their standard errors are presented. For residential SA care, the agency services only with 
Medicaid enrollment group is significantly associated with more days of residential SA care 
(28% increase), while the agency services only without Medicaid enrollment group is 
significantly associated with fewer days of care (56% decrease). Both agency services 
only groups are significantly and positively related to OP SA days of care: an estimated 18% 
increase for the agency services only with Medicaid enrollment group and an estimated 60% 
increase for the agency services only without Medicaid enrollment group. Finally, the agency 
services only without Medicaid enrollment group is associated with significantly more days of 
MH care than the any Medicaid service group (56% increase). Unlike in Table 2, no consistent 
pattern emerges with regard to the demographic control variables included in the linear 
regression. The length of the MH/SA service window is positively and significantly associated 
with days of care. Months of Medicaid enrollment are negatively and significantly associated 
with days of residential and OP SA care, but positively and significantly associated with days of 
MH care. 
 
 
 
 
 
Implications for Behavioral Health 
This analysis examined the service use patterns of individuals with an indication of an opiate use 
disorder using IDB data from Washington for the period 1996 through 1998. Among individuals 
with opiate use disorders, the receipt of at least one MH/SA service through Medicaid appears to 
be positively associated with IP SA service use in that only individuals who met this condition 
had any record of an IP SA service. The receipt of at least one MH/SA service through Medicaid 
was also positively associated with OP SA service and with MH service use among individuals 
with opiate use disorders. The use of only state MH/SA agency services, on the other hand, was 
positively associated with the use of residential SA services. 
The findings suggest that the regulatory restrictions faced by state agencies and Medicaid may 
drive observed patterns of care for individuals with opiate use disorders. Specifically, the finding 
that agency-only MH/SA service use is associated with higher rates of residential service use and 
with no IP SA service use is likely tied to regulatory differences between Medicaid and the state 
agencies in Washington. For example, SA block grant funds, which are a key source of funding 
for both DASA and MHD, could not be used for IP hospital care during the period covered by 
this analysis. This restriction most likely induced state agencies to route patients for whom 
outpatient care is insufficient to residential care. Similarly, the Medicaid Institutions of Mental 
Disorders exclusion prohibits payment for psychiatric services received by adults in residential 
care facilities with more than 16 beds and so may induce providers to route more severe patients 
to IP care rather than to residential care. This explanation suggests that using administrative data 
to track service use patterns may be misleading because the collection of service data is driven 
by regulatory environments and billing systems that may not capture the actual intensity of care 
given. 
The results are subject to several limitations. First, although the IDB represents one of the most 
comprehensive cross-system databases used to examine this critical issue to date, it does not 
capture all possible services that could be used by individuals with possible opiate use disorders 
in Washington. Other possible sources include self-pay, private insurance, and the Department of 
Veterans Affairs (VA) system, among others. Another important limitation common to all 
administrative databases is that the actual treatment need of the population studied is unknown, 
so definitive statements cannot be made about the appropriateness of the services received. 
Furthermore, because of the limited time frame of the IDB, data are unavailable for individuals 
who used MH/SA services either before 1996 or after 1998. As a result, it is possible that this 
study has not captured the full service use history of some individuals who appear in the 
treatment system briefly at the beginning or end of the study period. A final limitation of this 
study is that information on prescription drug use is not available in the agency service records 
contained in the IDB and is therefore not considered in this study. 
Despite these limitations, the analysis of service use patterns of individuals with possible opiate 
use disorders during the late 1990s offers key implications for today’s policy makers as they 
attempt to address issues surrounding the emergence of new opiates. First and foremost, if policy 
makers are trying to track the service use of a small but important segment of the overall SA 
population, using integrated data is a necessity. When funding for treatment services is cut in an 
effort to contain costs, it is important to determine if those services have simply been shifted to 
other state programs, reflecting little net cost savings for states overall. The present study 
combines state MH/SA agency data with state Medicaid data, but including additional data 
sources (e.g., VA or criminal justice system) would provide an even more complete picture of 
service use patterns. Second, the utility of administrative data for analyses such as these is often 
limited by the influence of the regulatory environment, clinical practice patterns, and the 
institutional history of the data systems used. Given that state and federal policy makers 
increasingly rely on administrative data to assess the performance of the treatment system, the 
results clearly highlight the need to better track service provision. SAMHSA’s IDB, therefore, 
represents the vanguard of a new, expansive, cross-agency philosophy regarding administrative 
data sources and serves as a model for new and more comprehensive data integration efforts. 
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